Personalized measurable residual disease assays for acute myeloid leukemia guided by whole-genome sequencing.
- DOI
- 10.3324/haematol.2026.300715
- Published
- 2026 Jul 23
- Container
- Haematologica
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3324/haematol.2026.300715,
title = {Personalized measurable residual disease assays for acute myeloid leukemia guided by whole-genome sequencing.},
author = {Ravindra N and Al-Ali RW and Lack J and Dalgard CL and VanCollenburg E and Corner A and Beppu L and Erba H and Othus M and Lindsley RC and Radich JP and Dillon LW and Hourigan CS},
year = {2026},
journal = {Haematologica},
doi = {10.3324/haematol.2026.300715},
url = {https://doi.org/10.3324/haematol.2026.300715}
}RIS
TY - JOUR TI - Personalized measurable residual disease assays for acute myeloid leukemia guided by whole-genome sequencing. AU - Ravindra N AU - Al-Ali RW AU - Lack J AU - Dalgard CL AU - VanCollenburg E AU - Corner A AU - Beppu L AU - Erba H AU - Othus M AU - Lindsley RC AU - Radich JP AU - Dillon LW AU - Hourigan CS PY - 2026 JO - Haematologica DO - 10.3324/haematol.2026.300715 UR - https://doi.org/10.3324/haematol.2026.300715 ER -
APA
N, R., RW, A., J, L., CL, D., E, V., A, C., L, B., H, E., M, O., RC, L., JP, R., LW, D., & CS, H. (2026). Personalized measurable residual disease assays for acute myeloid leukemia guided by whole-genome sequencing.. Haematologica. https://doi.org/10.3324/haematol.2026.300715
Source records
- pubmed · retrieved 2026-09-26T05:14:19.356Z